SHAREHOLDER BUYOUT INVESTIGATION: Does the $28.00 Per Share Buyout Price Shortchange STAAR Surgical Company (STAA) Investors? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm

Philadelphia, Pennsylvania--(Newsfile Corp. - September 26, 2025) - Kaskela Law LLC announces that it is investigating the adequacy of the shareholder buyout offer made to STAAR Surgical Company (NASDAQ: STAA) ("STAAR" or the "Company") investors to determine whether the proposal is fair and provides sufficient monetary consideration for STAA shares. Following the proposed transaction, STAAR shares will no longer be publicly traded.

Click here to request additional information about this investigation:  https://kaskelalaw.com/case/staar-surgical/

On August 5, 2025, STAAR announced that it had agreed to be acquired by Alcon at a price of $28.00 per share, which is significantly lower than the Company's 52-week high price of $38.60 per share.

The investigation so far has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and consideration unfair to the Company's shareholders. Additionally, STAAR's largest shareholder has publicly stated that its "serious concerns about the fairness and integrity of the sales process, in addition to the insufficient merger consideration, lead us to believe that the acquisition is not in the best interest of STAAR's shareholders."

STAAR shareholders are encouraged to promptly contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) to discuss this investigation and their important legal rights and options at (888) 715 - 1740, or by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/staar-surgical/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation.  For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com. 

This communication may constitute attorney advertising in certain jurisdictions.  

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268190